PMID: 9529409Apr 8, 1998Paper

Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study

BMJ : British Medical Journal
G LindbergA Melander

Abstract

To investigate possible associations between use of cardiovascular drugs and suicide. Cross sectional ecological study based on rates of use of eight cardiovascular drug groups by outpatients. A population based cohort study including users of drugs to control hypertension. The ecological study included 152 of Sweden's 284 municipalities. The cohort study included all inhabitants of one Swedish municipality who during 1988 or 1989 had purchased cardiovascular agents from pharmacies within the municipality. Six hundred and seventeen subjects (18.2%) were classified as users of calcium channel blockers and 2780 (81.8%) as non-users. Partial correlations (least squares method) between rates of use of cardiovascular drugs and age standardised mortality from suicide in Swedish municipalities. Hazard ratios for risk of suicide with adjustments for difference in age and sex in users of calcium channel blockers compared with users of other hypertensive drugs. Among the Swedish municipalities the use of each cardiovascular drug group except angiotensin converting enzyme inhibitors correlated significantly and positively with suicide rates. After adjustment for the use of other cardiovascular drug groups, as a substitute for the prevalen...Continue Reading

References

Oct 1, 1990·The British Journal of Psychiatry : the Journal of Mental Science·R H McAllister-Williams
Sep 23, 1989·BMJ : British Medical Journal·C BiriellE Sanz
Jan 17, 1986·JAMA : the Journal of the American Medical Association·J AvornS Weiss
Oct 1, 1986·The American Journal of Medicine·J K Kahn

❮ Previous
Next ❯

Citations

May 1, 2007·European Journal of Clinical Pharmacology·Torbjörn CallréusMorten Andersen
Oct 20, 1999·Journal of Clinical Epidemiology·W RathmannG Giani
Mar 23, 2006·Cardiovascular Drugs and Therapy·Philip A Poole-WilsonUNKNOWN ACTION Investigators
May 5, 2007·The American Heart Hospital Journal·Maurizio PompiliPaolo Girardi
Nov 14, 2013·Expert Review of Pharmacoeconomics & Outcomes Research·Pranav K GandhiI-Chan Huang
May 10, 2002·Pharmacoepidemiology and Drug Safety·Erik Bøg-HansenLennart Råstam
Aug 21, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·J Douglas Bremner, Peter McCaffery
Jan 12, 2007·The Journal of Clinical Hypertension·Marvin Moser
Jun 7, 2015·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Chien-Chia SuI-Jong Wang
Dec 1, 2001·Progress in Cardiovascular Diseases·J Muntwyler, F Follath
Nov 26, 2008·Pharmacoepidemiology and Drug Safety·H KnopfA Bertelsmann
Apr 27, 2002·Journal of Clinical Pharmacy and Therapeutics·J A Simpson, P C Hannaford
May 22, 2010·Human & Experimental Toxicology·Sule KalkanYesim Tuncok
Nov 20, 2001·Clinical Cardiology·M KeltaiM Tueth
Oct 7, 2011·Clinical Trials : Journal of the Society for Clinical Trials·Robert Temple
Jul 27, 1999·British Journal of Clinical Pharmacology·N R DunnR D Mann
Aug 9, 2003·Expert Opinion on Drug Safety·Joseph T Flynn
Oct 18, 2002·Journal of Clinical Epidemiology·Beatrice A GolombSarnoff A Mednick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.